MariMed agrees to acquire Kind Therapeutics USA for $20M; buys minority interests for $2M

MARIMED INC.

Acquires 100% of Kind Therapeutics for $20M: $13.5M cash, $6.5M in 4-year 6% promissory notes.
Also buys minority interests in two subsidiaries for $2M, gaining ~99.7% of Mari-MD and ~94.3% of Mia.
Kind holds Maryland medical cannabis licenses for cultivation, production, and provisional dispensary.
Closing subject to Maryland Medical Cannabis Commission approval; related litigation dismissed with prejudice.
CEO Bob Fireman expects another transformational year; MariMed already manages Kind's operations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.